Save this technology
close
Save to Existing Project
Save to a New Project
Combination Anti-Acne Product
Ferndale Healthcare United States flag United States
Abstract ID:
A unique patent pending combination, anti-acne formulation with 24 month stability at room temperature
Contact
RE:
Participants
You

A unique patent pending combination, anti-acne formulation with 24 month stability at room temperature.  This product has been evaluated in a battery of preclinical toxicology studies and a 101 subject, Phase 2 multicenter, clinical, proof-of-concept (POC) study in which favorable efficacy results were obtained.

Type of Business Relationship Sought

Outlicense or divestment

FEATURED
Last Updated Nov 2014
Technology Type THERAPEUTIC
Phase of Development CLINICAL TRIALS
CORPORATION

Opportunity Contact